Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 29, 2023
has subject area
- 06 Biological Sciences (FoR)
- 11 Medical and Health Sciences (FoR)
- Antibodies, Monoclonal, Humanized (MeSH)
- Humans (MeSH)
- Immunization (MeSH)
- Infant (MeSH)
- Microbiology (Science Metrix)
- Respiratory Syncytial Virus, Human (MeSH)
- Seasons (MeSH)
published in
- Journal of Infectious Diseases Journal